Home > Income Statement > NGL FINECHEM

NGL FINECHEM
Revenue

    Back to Income Statement
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹368 Cr₹339 Cr₹278 Cr₹318 Cr₹258 Cr

What is the latest Revenue of NGL FINECHEM ?

The latest Revenue ratio of NGL FINECHEM is ₹368 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹368 Cr
Mar2025₹339 Cr
Mar2024₹278 Cr
Mar2023₹318 Cr
Mar2022₹258 Cr

How is Revenue of NGL FINECHEM Trending?

Years Revenue % Change
Mar2026 ₹368 Cr
8.73
Mar2025 ₹339 Cr
21.79
Mar2024 ₹278 Cr
-12.42
Mar2023 ₹318 Cr
23.08
Mar2022 ₹258 Cr -

Compare Revenue of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹1,737.3 Cr -4.2% 9.4% 94.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,427.0 Cr 0.2% -4.1% 5.5% Stock Analytics
DIVIS LABORATORIES ₹239,982.0 Cr -3.1% -1.6% 47.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹175,196.0 Cr -1.2% -5% 29.4% Stock Analytics
CIPLA ₹107,746.0 Cr 2.3% -2% -13.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,894.0 Cr 2.2% 6.2% -2.5% Stock Analytics


NGL FINECHEM Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

-4.2%

9.4%

94.1%

SENSEX

3.8%

-0.6%

-9.1%


You may also like the below Video Courses